Business Context and Reporting Period
This Form 6-K filing by Ellomay Capital Ltd. is dated April 1, 2026. The report primarily serves to incorporate by reference a press release (Exhibit 99.1) containing financial results for the fourth quarter and full year ended December 31, 2025. Additionally, the filing details corporate governance updates regarding debenture amendments and the Board of Directors.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1) which is incorporated by reference but not reproduced in the body of this document.
Material Changes and Corporate Actions
- Debenture Amendments Approved: Holders of Series D-G debentures approved amendments to the deeds of trust on March 31, 2026, in connection with a change of control.
- Series D Convertible Debentures: The Company intends to decrease the conversion price from NIS 165 per share to the average closing price of the last 30 trading days plus 15%. Implementation is subject to court, shareholder, and exchange approvals; timing is currently uncertain.
- Series G Debentures: The Company removed a proposed amendment that would have eliminated the increase in the annual interest rate if the debentures were rated above Baa1.il.
- Board Leadership: Mr. Ben Sheizaf, Chairman of the Board, agreed to continue serving pending the appointment of a replacement, despite his prior notice to resign 30 days after the change of control.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance or management commentary on future financial performance. Key contingencies and risks identified include:
- Regulatory and Court Approval: The reduction in the Series D conversion price is contingent upon Israeli court approval and listing approvals from the NYSE American and Tel Aviv Stock Exchange.
- Uncertain Implementation: The Company explicitly states it cannot currently estimate whether or when the Series D conversion price adjustment will be implemented.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2025 financial results (revenue, net income, cash flow).
- Monitor the status of the Israeli court approval for the Series D debenture conversion price adjustment.
- Verify the timeline for the appointment of a new Chairman of the Board to replace Mr. Sheizaf.
- Confirm the final terms of the change of control transaction referenced in the March 23, 2026 Form 6-K.